BioHealth News Archive

Startup Maryland Announces Finalists for the 2017 STRT1UP Roadshow + Pitch Across Maryland

Startup Maryland Announces Finalists for the 2017 STRT1UP Roadshow + Pitch Across Maryland

Startup Maryland today unveiled the Overall Great Eight and other sub-category finalist for the Pitch Across Maryland Competitions. Startup Maryland is proud to showcase…

Read More
Tapping into America’s Biomedical Seed Fund

Tapping into America’s Biomedical Seed Fund

Looking for a deal in your backyard? The NIH is the world's largest investor in early stage life sciences companies. Over 1000 companies annually…

Read More
Mallinckrodt (MNK) Completes Acquisition Of Sucampo Pharmaceuticals (SCMP)

Mallinckrodt (MNK) Completes Acquisition Of Sucampo Pharmaceuticals (SCMP)

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it has closed the acquisition of Sucampo Pharmaceuticals, Inc., a global biopharmaceutical…

Read More
NIH funding fewer clinical trials, Johns Hopkins study shows – Baltimore Sun

NIH funding fewer clinical trials, Johns Hopkins study shows – Baltimore Sun

The National Institutes of Health has been funding fewer clinical trials in recent years, according to new Johns Hopkins University research. {iframe}http://www.baltimoresun.com/health/bs-hs-nih-clinical-trials-20180213-story.html{/iframe}

Read More
PIERIS PHARMACEUTICALS ANNOUNCES PRICING OF ITS PUBLIC OFFERING

PIERIS PHARMACEUTICALS ANNOUNCES PRICING OF ITS PUBLIC OFFERING

Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer, respiratory and other diseases,…

Read More
Please join the BioPark’s Monthly Networking Event

Please join the BioPark’s Monthly Networking Event

Host:  UM BioPark & Wexford Science + Technology Location:  UM BioPark The Nook Cafe 801 W. Baltimore Street Baltimore  Maryland  21201 Time: Thursday, February 22, 2018 5:00pm…

Read More
Dr. Richard Douglas Joins MaxCyte Board

Dr. Richard Douglas Joins MaxCyte Board

MaxCyte, the global cell-based medicines and technology company, announces that 30-year life sciences industry veteran Richard Douglas, Ph.D., has been appointed to the Company’s Board of Directors as an Independent Non-Executive Director.   {iframe}https://www.maxcyte.com/richard-douglas-joins-board/{/iframe}

Read More
A New Material Called “Superwood” Is Just As Strong As Steel

A New Material Called “Superwood” Is Just As Strong As Steel

Is wood the next advanced material? Scientists at the University of Maryland reported last week that they’ve discovered a way to treat wood to make…

Read More
NextGen Venture Partners Joins Brown Advisory

NextGen Venture Partners Joins Brown Advisory

Brown Advisory—an investment and strategic advisory firm committed to making a material and positive difference in the lives of its clients—is excited to join…

Read More
ABL Europe and SillaJen Expand Strategic Manufacturing Collaboration for Oncolytic Virus Therapies – ABL, Inc.

ABL Europe and SillaJen Expand Strategic Manufacturing Collaboration for Oncolytic Virus Therapies – ABL, Inc.

SillaJen, Inc., (KOSDAQ:215600), a clinical-stage, biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, and ABL Europe, an ABL, Inc. company…

Read More
Researchers Develop Breakthrough Technique to Combat Cancer Drug Resistance – Fischell Department of Bioengineering

Researchers Develop Breakthrough Technique to Combat Cancer Drug Resistance – Fischell Department of Bioengineering

The ability for cancer cells to develop resistance to chemotherapy drugs – known as multidrug resistance – remains a leading cause for tumor recurrence…

Read More
11 Startups with JHTV Ties Rank Among Baltimore’s Best – JHTV

11 Startups with JHTV Ties Rank Among Baltimore’s Best – JHTV

In the last six months, Personal Genome Diagnostics (PGDx) raised a $75 million series B, Harpoon Medical sold for $100 million and Sunayu acquired…

Read More
Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines

Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines

Lonza Pharma & Biotech and Denali Therapeutics (NASDAQ: DNLI) announced today an exclusive strategic partnership on Denali’s biologic pipeline products for neurodegenerative diseases. The…

Read More
Rexahn Reports Data from the Ongoing Phase 2a Clinical Trial of RX-3117 in Advanced Bladder Cancer at the American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) 2018 Annual Meeting (NYSE:RNN)

Rexahn Reports Data from the Ongoing Phase 2a Clinical Trial of RX-3117 in Advanced Bladder Cancer at the American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) 2018 Annual Meeting (NYSE:RNN)

Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, announced that updated safety and…

Read More
The University of Maryland is getting a new $50 million engineering building – The Diamondback

The University of Maryland is getting a new $50 million engineering building – The Diamondback

The University System of Maryland Board of Regents voted on Friday to approve the construction of a new engineering facility on the University of…

Read More